Zenith Drugs Board Meeting Date
Zenith Drugs will hold a board meeting on November 14, 2026 to consider unaudited standalone half-yearly results. Trading window stays closed until November 16, 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
Zenith Drugs will hold a board meeting on November 14, 2026 to consider unaudited standalone half-yearly results. Trading window stays closed until November 16, 2026.
Zenith Drugs won a ₹1.24 Crore tender from RMSCL for Pregabalin Capsules supply. The LOA confirms 226,944 units at ₹54.70 per unit.
Zenith Drugs won a tender from Uttar Pradesh Medical Supplies Corporation for Betamethasone Valerate cream. The ₹0.73 Crore contract value strengthens the company's pharmaceutical supply pipeline.
Zenith Drugs Board approved sale of a 5-hectare property in Indore for ₹13.75 Crore to ACE Engineering & Chemicals Pvt Ltd. Completion expected by November 2026.
Zenith Drugs Limited has been awarded a tender by Haryana Medical Services Corporation Limited to supply medicines for two years at Rs. 11.15 per unit.
Zenith Drugs Limited released the voting results and Scrutinizer's Report for its 26th Annual General Meeting conducted on September 29, 2026.
Zenith Drugs Limited has issued a notice for its 26th Annual General Meeting scheduled for September 29, 2026, to transact various ordinary and special business.
Zenith Drugs Limited announced the notice for its 26th AGM and appointed a secretarial auditor and a scrutinizer for the meeting.
Zenith Drugs Limited's board approved the allotment of 16,09,050 convertible warrants to promoters on a preferential basis. The aggregate consideration for this issuance is Rs. 6.99 Crore.